Invasive pneumococcal disease among children in Victoria

Authors

  • Min Liu Public Heath Training Scheme, Department of Human Services, 589 Collins Street Melbourne, Victoria 3000
  • Ross Andrews Communicable Diseases Section, Department of Human Services, Victoria; National Centre for Epidemiology and Population Health, Australian National University, Canberra
  • Joanne Stylianopoulos Microbiological Diagnostic Unit, Public Health Laboratory, University of Melbourne, Victoria
  • Catherine Ferreira Communicable Diseases Section, Department of Human Services, Victoria
  • Geoff Hogg Microbiological Diagnostic Unit, Public Health Laboratory, University of Melbourne, Victoria
  • Nyree Pyper Communicable Diseases Section, Department of Human Services, Victoria

DOI:

https://doi.org/10.33321/cdi.2003.27.61

Keywords:

invasive pneumococcal disease, enhanced surveillance, risk factors, vaccine, serotype, children

Abstract

This study analysed notification data from the first year of enhanced surveillance of invasive pneumococcal disease (IPD) in Victoria (1 July 2001 - 30 June 2002), with a focus on risk factors for infection and vaccination status among children under five years of age. Overall, there were 397 notifications (8.2 per 100,000 population), 131 (33%) were children under five years of age. The highest notification rates were among those aged less than two years (72.6 per 100,000 population) among children aged less than five years: bacteraemia without a primary focus of infection was the most common clinical presentation (64%); 89 per cent were hospitalised with the median length of stay being three days; four children (3%) died. There were 107 cases of a known serotype, 92% (n=98) were either in or closely related to those included in the 7-valent conjugate pneumococcal vaccine (7vPCV). Most cases (98%) were not eligible for free 7vPCV under the currently funded program in Victoria. Only one child had been vaccinated. The results from the first year of enhanced IPD surveillance in Victoria suggest consideration should be given to extending the publicly funded program to include all children under two years of age. Commun Dis Intell 2003;27:362-366.

Downloads

Download data is not yet available.

References

Forrest JM, McIntyre PB, Burgess MA. Pneumococcal disease in Australia. Commun Dis Intell 2000;24:89-92.

Musher DM. Streptococcus pneumoniae. In: Mandell GL, Douglas RG and Bennett JE, eds. Principles and practice of infectious diseases. 4th edn. Philadelphia: Churchill Livingstone, 2000:1811-1826.

Roche P, Krause K for the Enhanced Pneumococcal Surveillance Group of the Pneumococcal Working Party of the Communicable Diseases Network Australia. Invasive pneumococcal disease in Australia, 2001. Commun Dis Intell 2002;26:505-519.

National Health and Medical Research Council Health Advisory Committee. National Childhood Pneumococcal Vaccination Program: recommendations of the Australian Technical Advisory Group on Immunisation for a childhood pneumococcal vaccination program. National Health and Medical Research Council; October 2001

Victorian Government Department of Human Services, Public Health Division. Childhood pneumococcal disease immunisation information. Department of Human Services; May 2002 (0210202).

Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd edn. Philadelphia: WB Saunders, 1999:553-607.

National Health and Medical Research Council. The Australian Immunisation Handbook. 7th edn. Canberra: Australian Government Publishing Service, 2000:183-187.

McIntyre PB, Gilmour RE, Gilbert GL, Kakakios AM, Mellis CM. Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-1999. Med J Aust 2000;173:S22-S26.

Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46:1-24.

Hogg GG, Strachan JE, Lester RA. Invasive pneumococcal disease in the population of Victoria. Med J Aust 2000;173:S32-S35.

Fedson DS, Scott JA, Scott G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 1999;17:S11-S18.

Poland GA. The prevention of pneumococcal disease by vaccines: promises and challenges. [Review] Infect Dis Clin North Am 2001;15:97-122.

Peters TR, Edwards KM. The pneumococcal protein conjugate vaccines. J Paediatr 2000;137:416-420.

Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000;283:1460-1468.

Centres for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000;49(RR-9):1-38.

Hills SL, Hanna JN and Murphy D. Invasive pneumococcal disease in North Queensland, 2001. Commun Dis Intell 2002;26:520-524.

Downloads

Published

30/09/03

How to Cite

Liu, Min, Ross Andrews, Joanne Stylianopoulos, Catherine Ferreira, Geoff Hogg, and Nyree Pyper. 2003. “Invasive Pneumococcal Disease Among Children in Victoria”. Communicable Diseases Intelligence 27 (September):362-66. https://doi.org/10.33321/cdi.2003.27.61.

Issue

Vol. 27 (2003)

Section

Short report

Categories

License

Copyright (c) 2003 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>